|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/573 | (2006.01) |
| C07J 5/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 5/46 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3456330 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18198653.0 |
| Date of filing the European patent application | 2015-10-07 | |
| (97) | Date of publication of the European application | 2019-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation | 2021-08-10 |
| (30) | Number | Date | Country code |
| 14188063 | 2014-10-08 | EP |
| (72) |
Gerloni, Mara, US
|
| (73) |
Cosmo Technologies Ltd,
Riverside II Sir John Rogerson`s Quay,, Dublin 2,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Korteksolono 17 alfa-valeratas, skirtas naudoti navikų gydymui |
| CORTEXOLONE 17ALPHA-VALERATE FOR USE IN THE TREATMENT OF TUMOURS |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 11 | 289.00 EUR |
| 2026-10-07 |